Esophageal and laryngeal cancer incidentally found on [18F]fluorodeoxyglucose positron emission tomography/computed tomography during the staging workup for lung cancer

被引：7

作者：

Jeon, Se Yong ^{[1
]}

Ahn, Se Han ^{[1
]}

Kim, Cheol Hyeon ^{[1
]}

Lim, Sang Moo ^{[2
]}

Koh, Jae Soo ^{[3
]}

Lee, Jae Cheol ^{[1
]}

机构：

[1] Korea Canc Ctr Hosp, Dept Internal Med, Seoul 139706, South Korea

[2] Korea Canc Ctr Hosp, Dept Nucl Med, Seoul 139706, South Korea

[3] Korea Canc Ctr Hosp, Dept Pathol, Seoul 139706, South Korea

来源：

CLINICAL LUNG CANCER | 2008年 / 9卷 / 04期

关键词：

hypermetabolic lesions; mucosal lesions; squamous cell carcinoma; triple primary tumors;

D O I：

10.3816/CLC.2008.n.035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

During staging workup for lung cancer of a 74-year-old man, 2 more incidental tumors were found on [F-18]fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT). The 3 sites with cancer in this patient involved organs in which field cancerization has often been described, suggesting that triple primary tumors were more probable than metastasis. After treating them separately, complete response was achieved and sustained for > 2 years. The use of FDG-PET/CT seems necessary to evaluate patients with cancer, especially when there is a reasonable chance for cure. Incidentally identified lesions on FDG-PET/CT should be thoroughly explored to rule out the presence of hidden malignancy and the possibility of synchronous multiple primary tumors.

引用

页码：230 / 231

页数：2

共 10 条

[1] Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: Histopathologic comparison
Agress, H
Cooper, BZ
[J]. RADIOLOGY, 2004, 230 (02) : 417 - 422
[2] Braakhuis BJM, 2003, CANCER RES, V63, P1727
[3] COPPER MP, 1993, CANCER, V71, P825, DOI 10.1002/1097-0142(19930201)71:3<825::AID-CNCR2820710327>3.0.CO
[4] 2-X
[5] Widely dispersed p53 mutation in respiratory epithelium - A novel mechanism for field carcinogenesis
Franklin, WA
Gazdar, AF
Haney, J
Wistuba, II
LaRosa, FG
Kennedy, T
Ritchey, DM
Miller, YE
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) : 2133 - 2137
[6] Ishimori T, 2005, J NUCL MED, V46, P752
[7] Prevo LJ, 1999, CANCER RES, V59, P4784
[8] SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO
[9] 2-Q
[10] SOZZI G, 1995, CANCER RES, V55, P135

← 1 →